Integrated diagnosis of grade 3-4 gliomas using targeted next-generation sequencing and traditional diagnostic data, and its overall implications on patient management

医学 医学物理学 计算机科学 数据科学
作者
Duaa Kanan,Şebnem Safi,Tarek Kanan,Serkan Çelik,Bala Başak Öven,Özlem Yapıcıer
出处
期刊:Brain disorders [Elsevier]
卷期号:14: 100126-100126
标识
DOI:10.1016/j.dscb.2024.100126
摘要

Adult gliomas vary significantly in terms of their genetics, epigenetics, phenotypes as well as clinical outcomes1. Optimal tumor classification that leads to more precise diagnoses, and which influences therapy selection is hence critically important. Targeted next-generation sequencing (NGS) is a highly reliable and efficient novel tool for the identification of biomarkers for the diagnosis of CNS tumors2. In this study, we aimed to determine the implications of integrating NGS findings with the traditional diagnostic data on clinical diagnostics and patient management. All patients who were diagnosed with glioma at our institution between 2019-2020 and whose tumor biopsy materials were analyzed by both traditional histomorphological and immunohistochemical diagnostic techniques as well as NGS were included in our study. Patients' information was retrieved from the electronic medical record. Data analyzed included the histopathologic diagnosis, tumor grade, ki67, and the mutation status of TP53 and /or IDH, as well as other genes such as BRAF and HER2 for some patients. The overall concordance between NGS and the traditional diagnostic tools for IDH and TP53 mutations was also evaluated. Further, we derived the overall survival of patients using the Kaplan-Meier estimate. We identified 9 patients with grade 3-4 gliomas whose biopsy materials were analyzed by NGS as well as traditional diagnostic tools. Our patients were 33.3% females and had a median age of 43 years old at diagnosis. In terms of the identification of gene mutations by NGS in comparison to immunohistochemistry (IHC), it was found that the concordance for mutant identification was 77.8% (7/9) for IDH mutations and 55.6% (5/9) for TP53 mutations. NGS further led to a change in patient management in which evidence-based targeted therapy (dabrafenib plus trametinib) was used for one patient (11.1%) with BRAF V600E mutated astroblastoma. Integrating NGS with traditional diagnostic tools for the diagnosis of gliomas can have significant implications on patients. Such integrated diagnosis can lead to more precise diagnosis, enhanced identification of molecular markers, and offers the potential of using targeted therapies for patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
DZWyyyy发布了新的文献求助10
刚刚
1秒前
风趣的老太应助樱悼柳雪采纳,获得10
1秒前
1秒前
1秒前
Ricey完成签到,获得积分10
1秒前
1秒前
1秒前
蛋蛋发布了新的文献求助10
2秒前
大模型应助mengmenglv采纳,获得10
2秒前
脑洞疼应助阮楷瑞采纳,获得10
3秒前
dili完成签到,获得积分10
3秒前
yookia应助光亮小笼包采纳,获得10
3秒前
LELE发布了新的文献求助10
4秒前
4秒前
蓉城完成签到,获得积分10
4秒前
jin晨发布了新的文献求助10
4秒前
4秒前
Refuel发布了新的文献求助10
5秒前
5秒前
5秒前
笑点低怀亦完成签到,获得积分10
5秒前
6秒前
6秒前
皮蛋s周完成签到 ,获得积分20
6秒前
7秒前
蛋蛋完成签到,获得积分10
7秒前
8秒前
水电费完成签到,获得积分20
8秒前
杨瑞东完成签到,获得积分10
8秒前
汉堡包应助辛勤的寄瑶采纳,获得10
8秒前
8秒前
每篇文献都读懂完成签到,获得积分10
8秒前
鹿lu应助大胆冬莲采纳,获得40
9秒前
9秒前
Leo完成签到,获得积分10
10秒前
小羊完成签到,获得积分20
10秒前
马文杰完成签到,获得积分10
10秒前
大大彬完成签到 ,获得积分10
10秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974643
求助须知:如何正确求助?哪些是违规求助? 3519094
关于积分的说明 11196979
捐赠科研通 3255182
什么是DOI,文献DOI怎么找? 1797700
邀请新用户注册赠送积分活动 877100
科研通“疑难数据库(出版商)”最低求助积分说明 806130